Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty & Preceptor Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Renal & Urology
  4. UTIs

UTIs

  • Benign Prostatic Hypertrophy (15)
  • Cystitis (2)
  • Drug-Induced Nephrotoxicity (100)
  • Drug Use in Renal Insufficiency (220)
  • Hyperkalemia (13)
  • Hypokalemia (1)
  • Hyponatremia (4)
  • Incontinence (6)
  • Kidney Cancer (1)
  • Kidney Disease (39)
  • Kidney Stones (16)
  • Nephrology (52)
  • Overactive Bladder (24)
  • Resources (62)
  • Urinary Retention (8)
  • UTIs (66)
  • Urine Drug Testing (15)
46 - 60 of 66 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Watch for Dosing Confusion with Ceftolozane/Tazobactam March 2015
Commentary: New Drug: Zerbaxa (Ceftolozane/Tazobactam) March 2015
Commentary: Antimicrobial Stewardship November 2014
Article: Advise Taking "Flozins" in the Morning October 2014
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
Article: Encourage Prescribers to Include Notes on Kids' Quinolone Rxs August 2014
PL Voices: Safety of Quinolone Antibiotics in Children August 2014
Article: Farxiga (far-SEE-guh) for type 2 diabetes will soon hit shelves March 2014
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: how to PREVENT recurrent urinary tract infections April 2012
Article: Which antibiotics should you recommend for urinary tract infections in elderly patients December 2011
Chart: Choosing a UTI Antibiotic for Elderly Patients December 2011
Article: avoid quinolones for UNCOMPLICATED urinary tract infections (UTIs) in women April 2011
Commentary: Treatment of Acute Uncomplicated Urinary Tract Infections in Women April 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved